- The U.S. will invest $3 billion in the COVID-19 vaccine supply chain within the coming weeks, White House coronavirus response coordinator Jeff Zients said Thursday.
- The investment will allow manufacturers to add new production lines and facilities and fulfill President Biden's pledge to be the "arsenal of vaccines for the world," Zients said.
- Zients also added that focus areas include lipids, bioreactor bags, tubing, needles, syringes, and personal protective equipment.
- The White House has not yet selected specific companies to receive the funds.
- U.S. demand for COVID-19 vaccines remains high as the White House prepares to begin offering a third booster shot to Americans later this month, pending a regulator go ahead.
- Related Content: Biden's COVID-19 Booster Plan Faces Resistance From Medical Experts.
- In June, Officials announced that the Biden Administration plans to invest more than $3.2 billion for COVID-19 antiviral medicines.
- Related: Biden Administration Devotes Over $3.2B For Development Of Oral Antiviral Therapies For COVID-19.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in